Table 4.
Subgrouped by | No. of trials | Effect size1 | 95% CI | I2 (%) | P for heterogeneity |
---|---|---|---|---|---|
Weight | |||||
Dose | |||||
Under 100 mg/day | 8 | 0.64 | −1.83, 3.11 | 0.0 | 1.000 |
Over 100 mg/day | 7 | −0.59 | −2.81, 1.62 | 0.0 | 1.000 |
Duration | |||||
Under 8 weeks | 4 | −0.04 | −1.69, 1.60 | 0.0 | 1.000 |
Over 8 weeks | 11 | 0.1 | −1.75, 1.96 | 0.0 | 1.000 |
BMI | |||||
Dose | |||||
Under 100 mg/day | 10 | 0.09 | −0.69, 0.87 | 0.0 | 1.000 |
Over 100 mg/day | 7 | −0.15 | −0.76, 0.46 | 0.0 | 1.000 |
Duration | |||||
Under 8 weeks | 5 | −0.06 | −1.11, 0.99 | 0.0 | 1.000 |
Over 8 weeks | 12 | −0.06 | −0.60, 0.48 | 0.0 | 1.000 |
1Calculated by Random-effects model. CI=Confidence interval; BMI=Body mass index